← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2012Last known activity
Apr 30, 2024
Timeline
2000s
- Jun 1, 2004
Academic and Community Cancer Research United— Founded
Drugs by trial phase (83 distinct, 52 trials)
Phase 3 (13 own, 0 via acquisition)
Phase 2 (65 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma, Follicular
- Biliary Tract Neoplasms
- Breast Carcinoma In Situ
- Breast Neoplasms
- Carcinoma
- Carcinoma, Ductal
- Carcinoma, Ductal, Breast
- Carcinoma in Situ
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Islet Cell
- Carcinoma, Lobular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Papillary
- Carcinoma, Renal Cell
- Cholangiocarcinoma
- Colonic Neoplasms
- Colorectal Neoplasms
- Communicable Diseases
- Coronavirus Infections
- Disease Progression
- Embolism
- Esophageal Neoplasms
- Fanconi Anemia
- Gastrinoma
- Glucagonoma
- Hodgkin Disease
- Hot Flashes
- Infections
- Insulinoma
- Laboratory Infection
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Melanoma
- Multiple Myeloma
- Neoplasms
- Neoplasms, Plasma Cell
- Neuroendocrine Tumors
- Pancreatic Neoplasms
- Prostatic Neoplasms
- Pulmonary Embolism
- Rectal Neoplasms
- Severe Acute Respiratory Syndrome
- Somatostatinoma
- Stomach Neoplasms
- Thromboembolism
- Thrombosis
- Thyroid Cancer, Papillary
- Thyroid Diseases
- Thyroid Neoplasms
- Triple Negative Breast Neoplasms
- Unilateral Breast Neoplasms
- Venous Thromboembolism
- Venous Thrombosis
- Waldenstrom Macroglobulinemia
Recent trials (50)
- NCT06160206Overall official - principal investigatorPhase 2Apr 30, 2024
- NCT06160206Lead sponsorPhase 2Apr 30, 2024
- NCT06238648Lead sponsorPhase 2Jan 31, 2024
- NCT06238648OfficialPhase 2Jan 31, 2024
- NCT05910801Lead sponsorPhase 2Dec 29, 2023
- NCT05910801Overall official - principal investigatorPhase 2Dec 29, 2023
- NCT05194293Lead sponsorPhase 2Mar 1, 2023
- NCT05194293Overall official - principal investigatorPhase 2Mar 1, 2023
- NCT05199285Lead sponsorPhase 2Jan 30, 2023
- NCT05199285Overall official - principal investigatorPhase 2Jan 30, 2023
- NCT05356897Overall official - principal investigatorPhase 2Nov 30, 2022
- NCT05356897Lead sponsorPhase 2Nov 30, 2022
- NCT05168163Overall official - principal investigatorPhase 2May 27, 2022
- NCT05168163Lead sponsorPhase 2May 27, 2022
- NCT05246670Lead sponsorPhase 2May 16, 2022
Details
- Founded
- Rochester, MN, US Jun 1, 2004
- Last known activity
- Apr 30, 2024